These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
6. Performance effects of acute β-alanine induced paresthesia in competitive cyclists. Bellinger PM; Minahan CL Eur J Sport Sci; 2016; 16(1):88-95. PubMed ID: 25636080 [TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
8. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years. Kisicki JC; Fiske K; Lyne A Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Two β-Alanine Dosing Protocols on Muscle Carnosine Elevations. Church DD; Hoffman JR; Varanoske AN; Wang R; Baker KM; La Monica MB; Beyer KS; Dodd SJ; Oliveira LP; Harris RC; Fukuda DH; Stout JR J Am Coll Nutr; 2017; 36(8):608-616. PubMed ID: 28910200 [TBL] [Abstract][Full Text] [Related]
11. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial. Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study. Davidson MH; Bays H; Rhyne J; Stein E; Rotenberg K; Doyle R Clin Ther; 2005 Jun; 27(6):715-27. PubMed ID: 16117978 [TBL] [Abstract][Full Text] [Related]
13. Effects of β-alanine supplementation on performance and body composition in collegiate wrestlers and football players. Kern BD; Robinson TL J Strength Cond Res; 2011 Jul; 25(7):1804-15. PubMed ID: 21659893 [TBL] [Abstract][Full Text] [Related]
14. The effect of beta-alanine supplementation on isokinetic force and cycling performance in highly trained cyclists. Howe ST; Bellinger PM; Driller MW; Shing CM; Fell JW Int J Sport Nutr Exerc Metab; 2013 Dec; 23(6):562-70. PubMed ID: 23630052 [TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
16. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder. Nasser A; Hull JT; Chaturvedi SA; Liranso T; Odebo O; Kosheleff AR; Fry N; Cutler AJ; Rubin J; Schwabe S; Childress A CNS Drugs; 2022 Aug; 36(8):897-915. PubMed ID: 35896943 [TBL] [Abstract][Full Text] [Related]
17. Effects of 4 Weeks of β-Alanine Supplementation on Swim-Performance Parameters in Water Polo Players. Brisola GMP; Milioni F; Papoti M; Zagatto AM Int J Sports Physiol Perform; 2017 Aug; 12(7):943-950. PubMed ID: 27967270 [TBL] [Abstract][Full Text] [Related]
18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
19. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults. Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901 [TBL] [Abstract][Full Text] [Related]
20. Prospective, randomized, double-blinded, placebo-controlled study on safety and tolerability of the krill powder product in overweight subjects with moderately elevated blood pressure. Sarkkinen ES; Savolainen MJ; Taurio J; Marvola T; Bruheim I Lipids Health Dis; 2018 Dec; 17(1):287. PubMed ID: 30572894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]